Bluebird Bio Inc. (NASDAQ:BLUE)

CAPS Rating: 4 out of 5

BLUE News and Commentary

Caps

How do you think BLUE will perform against the market?

Add Stock to CAPS Watchlist

All Players

265 Outperform
19 Underperform
 

All-Star Players

85 Outperform
7 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top BLUE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Exanut (57.39)
Submitted January 17, 2016

They have pulled off what no other company was able to do successfully to date: gene therapy. This is a paradigm shift in treating hereto untreateable diseases. I don't expect the road to be easy as far as investing with this company, but I do think… More

TMFFlygal (98.94)
Submitted December 08, 2015

Selling for a while after the huge drop today, good for a trade

BLUE VS S&P 500 (SPY)

Fools bullish on BLUE are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about BLUE.

Recs

0
Member Avatar TurksFan (52.83) Submitted: 4/7/2018 12:49:37 PM : Outperform Start Price: $168.50 BLUE Score: -1.69

Starting my research into biotechs

Recs

0
Member Avatar newbuddha (80.14) Submitted: 3/26/2018 12:49:14 PM : Outperform Start Price: $183.45 BLUE Score: -9.92

Novel approach to treatment will likely yield some successful treatments to conditions that have large addressable markets. Additionally, Bluebird Bio's large asset base gives them time to fund their trials without need to generate a profit in the near term.

Recs

0
Member Avatar InvestRight (82.84) Submitted: 3/26/2018 12:14:06 PM : Outperform Start Price: $184.46 BLUE Score: -10.39

Good biotech and future of medicine.

Leaderboard

Find the members with the highest scoring picks in BLUE.

Score Leader

portefeuille12

portefeuille12 (51.43) Score: +747.40

The Score Leader is the player with the highest score across all their picks in BLUE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
portefeuille12 51.43 4/16/2014 Outperform 5Y $19.11 +792.20% +44.80% +747.40 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. efarev 98.82 11/5/2013 Outperform 5Y $20.53 +730.49% +52.76% +677.74 0 Comment
portefeuille2 99.48 4/11/2014 Outperform 5Y $20.74 +722.08% +47.82% +674.26 0 Comment
portefeuille3 98.29 4/11/2014 Outperform 5Y $20.74 +722.08% +47.94% +674.14 0 Comment
portefeuille6 99.66 4/11/2014 Outperform 5Y $20.91 +715.40% +48.14% +667.26 0 Comment
johninmadison 76.70 4/7/2014 Outperform 5Y $21.07 +709.21% +44.64% +664.57 0 Comment
HoosierDoozer 45.45 2/5/2014 Outperform 5Y $20.84 +718.14% +53.84% +664.30 0 Comment
portefeuille 98.82 4/8/2014 Outperform 5Y $21.44 +695.24% +45.87% +649.38 1 Comment
jack0071 71.43 1/8/2014 Outperform 5Y $21.47 +694.13% +46.57% +647.56 0 Comment
jtothes 69.28 2/14/2014 Outperform 3Y $21.88 +679.25% +47.06% +632.19 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBMOCapital < 20 6/6/2017 Outperform NS $95.43 +78.67% +10.50% +68.17 0 Comment
TrackStandpoint 37.59 5/30/2017 Outperform 5Y $78.60 +39.82% +0.31% +39.51 6/16/2017 @ $109.90 0 Comment
TrackJimCramer 85.09 5/27/2015 Outperform 3W $189.69 -10.12% +26.42% -36.53 0 Comment
TrackJimCramer 85.09 3/13/2015 Underperform 3W $119.93 +58.17% +3.34% -54.83 5/27/2015 @ $189.69 0 Comment
TrackPiperJaff 87.12 12/9/2014 Outperform NS $77.42 +120.23% +31.57% +88.66 0 Comment
TrackRothCapital 73.08 9/22/2014 Outperform NS $36.70 +364.58% +34.21% +330.37 0 Comment
TrackJimCramer 85.09 3/20/2014 Outperform 3W $26.83 +347.00% +9.63% +337.37 3/13/2015 @ $119.93 0 Comment
TrackWedbush 88.54 7/15/2013 Outperform NS $32.37 +426.72% +60.08% +366.64 0 Comment

Featured Broker Partners